2.44
price down icon0.41%   -0.01
after-market Dopo l'orario di chiusura: 2.45 0.01 +0.41%
loading

Anebulo Pharmaceuticals Inc Azioni (ANEB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
26.89%
1.8923
2.5882 2.4121 1.6643 2.7605
Interest Income/Expense
0.10
- - - -
Operating Income/Loss
26.89%
-1.8923
-2.5882 -2.4121 -1.6643 -2.7605
Nonoperating Income/Loss
72.76%
0.2162
0.1251 0.2114 0.0107 0.0431
Income/Loss From Continuing Operations Before Tax
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Income/Loss From Continuing Operations After Tax
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Net Income/Loss
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
49.86%
41.08
27.42 25.93 25.93 25.79
Diluted Average Shares
49.86%
41.08
27.42 25.93 25.93 25.79
Basic Earnings Per Share
55.56%
-0.04
-0.09 -0.08 -0.06 -0.11
Diluted Earnings Per Share
55.56%
-0.04
-0.09 -0.08 -0.06 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):